SCN5A and malignant colon neoplasm: Recently, it has been shown that pharmacological and transcriptional inhibition of rho-associated protein kinase (ROCK) increases the expression of NaV1.5 channels at the plasma membrane of colon cancer cells, boosting their invasive capacity [25].